SpineGuard

Investors

Contact us

Investor Information

Stéphane Bette - Director, Co-Founder and Chief Executive Officer
Stéphane Bette,
Co founder and Deputy CEO
Pierre Jérôme,
Co founder, CEO & Chairman

Dear Shareholders,

Our co-founders, Pierre Jérôme and Stéphane Bette, provide direct answers to key shareholder questions about SpineGuard’s strategy, financial situation, and future prospects. View the management message

Read the latest Financial News

 

Stock Information

Stock exchange information

  • ISIN code: FR0011464452
  • Stock Quote: ALSGD
  • Number of shares: 62.227.957
  • Sector: Medical technologies
  • Principal Index: Alternext All-share
  • Exchange: Euronext-Growth
  • Place of listing: Euronext Paris (France)
  • Eligibility to French PEA/SRD: Yes/No
  • Eligibility French PEA-PME: Yes

Financial agenda

  • January 10, 2025: 2024 Full-Year Sales
  • April 15, 2025: 2024 Full-Year Results
  • April 15, 2025: 2025 First-Quarter Sales
  • June 12, 2025: Annual Shareholders Meeting (1st summoning)
  • July 2, 2025: Annual Shareholders Meeting (2nd summoning if required)
  • July 9, 2025: 2025 First-Half Sales
  • September 10, 2025: 2025 First-Half Results
  • October 9, 2025: 2025 Third-Quarter Sales

Analysts

Others

  • Liquidity contract: Tradition Securities And Futures (TSAF)
  • Auditors: Grant Thornton
  • Listing Sponsor: Swiss Life Banque Privée

Shareholders structure

(June 7th, 2024)

Stock quotes

  • To check the stock quote in real time, click here

For any request, don't hesitate to contact us

M